2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EUROINVENT <strong>2012</strong><br />
suffering hemophilia, Jehovah witness &cancer patients(in<br />
whom stitches are risky). Innovative design with special fixation<br />
mechanism, cheap, disposable, effective, can be used after all<br />
vaginal surgeries& normal delivery to stop bleeding from vaginal<br />
wounds, by exerting even pressure inside vagina, with possible<br />
use of haemostatic or sealant glues and cooling through same<br />
device. It decreases the blood transfusion need and reduce costs<br />
due to obstetric hemorrhage(sutures ,blood products, staff<br />
working hours, patients hospital stay..etc) by 1/3 in hospitals<br />
,more over sanitary method that reduce infection rate. The<br />
invention device consists of 3 essential parts the upper horizontal<br />
fixed size inflatable ring for fixation inside vagina and lower<br />
vertical flexible size rubber tube with vales at the distal end of<br />
the vertical tube and the inflating device (manual /automatic).<br />
4.4.<br />
Title Novel treatment for multiple sclerosis and Autoimmune diseases.<br />
Authors Sherif Salah abdul Aziz Hussin<br />
Institution Cairo university, Faculty of Vet. Medicine, Egypt<br />
Patent no. WO 2011/127936 A1<br />
Description<br />
The invention relates to use pharmaceutical compositions share<br />
different biological active molecules for producing medicament<br />
utilized for the treatment of multiple sclerosis, Rheumatoid<br />
arthritis and related inflammatory diseases by specifically block<br />
cytokines receptors and inflammatory pathway.<br />
4.5.<br />
Title Antiviral combination for treatment HCV & HBV<br />
Authors Sherif Salah abdul Aziz Hussin<br />
Institution Cairo university, Faculty of Vet. Medicine, Egypt<br />
Patent no. WO 2008/092466 A1<br />
Description<br />
This invention introduce novel pathophysiology and therapy<br />
described that HCV play a specific role in disturbance the<br />
balance between two opposing enzymes mechanisms [Matrix<br />
Mineralloprotinases MMPase, tissue inhibitors of<br />
mineralloprotinases TIMPase 1 to 4]and[ tissue plasminogen<br />
activator t-PA, Plasminogen activator inhibitor-2PAI-2].<br />
Through activation of both MMPase and t-PA in turn the liver<br />
Class 4<br />
76
Change language